US2009286873A1PendingUtilityA1
AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
Est. expiryApr 12, 2024(expired)· nominal 20-yr term from priority
Inventors:Stephen T. MillerKarina B. XavierMichiko E. TagaShawn R. CampagnaMartin F. SemmelhackBonnie L. BasslerFrederick Hughson
C07K 2299/00A61K 38/00C07H 3/02C07H 7/02A61P 33/04C07K 14/255Y02A50/30
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to crystals comprising apo-LsrB and holo-LsrB. The structure of holo-LsrB identifies a tetrahydroxytetrahydrofuran derived from 4,5-dihydroxy-2,3-pentanedione (DPD) as the active autoinducer-2 (AI-2) molecule in Salmonella typhimurium . The X-ray crystallographic data can be used in a drug discovery method. Additionally the invention provides AI-2 analogs based on this discovery as well as pharmaceutical compositions containing those analogs.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A compound represented by formula I or formula J:
wherein Y is hydrogen or hydroxyl; and
R is lower alkyl;
or a pharmaceutically acceptable salt thereof.
5 . (canceled)
6 . A compound represented by formula K or formula L:
wherein
Y is hydrogen or hydroxyl;
X and Z are independently hydrogen, lower alkyl or hydroxyl; and
R is lower alkyl;
or a pharmaceutically acceptable salt thereof.
7 - 9 . (canceled)
10 . A pharmaceutical composition comprising one or more compounds of claim 4 in admixture with a pharmaceutically acceptable carrier.
11 . A pharmaceutical composition comprising one or more compounds of claim 6 in admixture with a pharmaceutically acceptable carrier.
14 - 39 . (canceled)Join the waitlist — get patent alerts
Track US2009286873A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.